{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:38:35Z","timestamp":1769121515719,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Temporal trends in clinical composition and outcome in dilated cardiomyopathy (DCM) are largely unknown, despite considerable advances in heart failure management. We set out to study clinical characteristics and prognosis over time in DCM in Sweden during 2003\u20132015.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>DCM patients (n\u2009=\u20097873) from the Swedish Heart Failure Registry were divided into three calendar periods of inclusion, 2003\u20132007 (Period 1, n\u2009=\u20092029), 2008\u20132011 (Period 2, n\u2009=\u20093363), 2012\u20132015 (Period 3, n\u2009=\u20092481). The primary outcome was the composite of all-cause death, transplantation and hospitalization during 1\u00a0year after inclusion into the registry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over the three calendar periods patients were older (<jats:italic>p<\/jats:italic>\u2009=\u20090.022), the proportion of females increased (mean 22.5%, 26.4%, 27.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0001), left ventricular ejection fraction was higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.0014), and symptoms by New York Heart Association less severe (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Device (implantable cardioverter defibrillator and\/or cardiac resynchronization) therapy increased by 30% over time (mean 11.6%, 12.3%, 15.1%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). The event rates for mortality, and hospitalization were consistently decreasing over calendar periods (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001 for all), whereas transplantation rate was stable. More advanced physical symptoms correlated with an increased risk of a composite outcome over time (<jats:italic>p<\/jats:italic>\u2009=\u20090.0043).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>From 2003 until 2015, we observed declining mortality and hospitalizations in DCM, paralleled by a continuous change in both demographic profile and therapy in the DCM population in Sweden, towards a less affected phenotype.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02124-0","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T08:03:04Z","timestamp":1624003384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003\u20132015"],"prefix":"10.1186","volume":"21","author":[{"given":"Helen","family":"Sj\u00f6land","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Silverdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entela","family":"Bollano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"issue":"9","key":"2124_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531\u201347.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2124_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"HP Schultheiss","year":"2019","unstructured":"Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1):32.","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"2124_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807\u201316.","journal-title":"Circulation"},{"issue":"1","key":"2124_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/eurheartj\/eht278","volume":"35","author":"A Barasa","year":"2014","unstructured":"Barasa A, Schaufelberger M, Lappas G, Swedberg K, Dellborg M, Rosengren A. Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J. 2014;35(1):25\u201332.","journal-title":"Eur Heart J"},{"issue":"1","key":"2124_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/eurjhf\/hfp175","volume":"12","author":"A Jonsson","year":"2010","unstructured":"Jonsson A, Edner M, Alehagen U, Dahlstr\u00f6m U. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12(1):25\u201331.","journal-title":"Eur J Heart Fail"},{"key":"2124_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2020.616273","volume":"7","author":"A Postigo","year":"2020","unstructured":"Postigo A, Mart\u00ednez-Sell\u00e9s M. Sex influence on heart failure prognosis. Front Cardiovasc Med. 2020;7:1\u201310.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2124_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ejhf.16","volume":"16","author":"M Merlo","year":"2014","unstructured":"Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16(3):317\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2124_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/CIRCHEARTFAILURE.112.000120","volume":"6","author":"G Castelli","year":"2013","unstructured":"Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management. Circ Heart Fail. 2013;6(5):913\u201321.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"2124_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/ejhf.1914","volume":"22","author":"M Merlo","year":"2020","unstructured":"Merlo M, Cannat\u00e0 A, Pio Loco C, Stolfo D, Barbati G, Artico J, Gentile P, De Paris V, Ramani F, Zecchin M, Gigli M, Pinamonti B, Korcova R, Di Lenarda A, Giacca M, Mestroni L, Camici PG, Sinagra G. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2020;22(7):1111\u201321.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"2124_CR10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension (Dallas, TX: 1979). 2003;42(6):1206\u201352.","journal-title":"Hypertension (Dallas, TX: 1979)."},{"issue":"9","key":"2124_CR11","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 ESH-ESC Practice Guidelines For The Management Of Arterial Hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25(9):1751\u201362.","journal-title":"J Hypertens"},{"issue":"7","key":"2124_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens"},{"issue":"12","key":"2124_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","volume":"373","author":"MR Cowie","year":"2015","unstructured":"Cowie MR, Woehrle H, Wegscheider K, Angermann C, d\u2019Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373(12):1095\u2013105.","journal-title":"New Engl J Med"},{"issue":"4","key":"2124_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11936-018-0624-0","volume":"20","author":"M Tsai","year":"2018","unstructured":"Tsai M, Khayat R. Sleep apnea in heart failure. Curr Treat Options Cardiovasc Med. 2018;20(4):33.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"10","key":"2124_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Str\u00f6mberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10(10):933\u201389.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2124_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","volume":"26","author":"MS Nieminen","year":"2005","unstructured":"Nieminen MS, B\u00f6hm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(4):384\u2013416.","journal-title":"Eur Heart J"},{"issue":"14","key":"2124_CR17","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K\u00f8ber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R\u00f8nnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847.","journal-title":"Eur Heart J"},{"issue":"8","key":"2124_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/S0735-1097(02)02304-5","volume":"40","author":"AP Maggioni","year":"2002","unstructured":"Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2002;40(8):1414\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"9386","key":"2124_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","volume":"362","author":"CB Granger","year":"2003","unstructured":"Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet (London, England). 2003;362(9386):772\u20136.","journal-title":"Lancet (London, England)"},{"issue":"3","key":"2124_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New Engl J Med. 2005;352(3):225\u201337.","journal-title":"New Engl J Med"},{"issue":"11","key":"2124_CR21","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/europace\/euq329","volume":"12","author":"DA Theuns","year":"2010","unstructured":"Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace. 2010;12(11):1564\u201370.","journal-title":"Europace"},{"issue":"46","key":"2124_CR22","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","volume":"34","author":"JG Cleland","year":"2013","unstructured":"Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34(46):3547\u201356.","journal-title":"Eur Heart J"},{"issue":"4","key":"2124_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ejhf.929","volume":"20","author":"LH Lund","year":"2018","unstructured":"Lund LH, Svennblad B, Dahlstr\u00f6m U, St\u00e5hlberg M. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure. Eur J Heart Fail. 2018;20(4):769\u201377.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"2124_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","volume":"369","author":"F Ruschitzka","year":"2013","unstructured":"Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369(15):1395\u2013405.","journal-title":"N Engl J Med"},{"key":"2124_CR25","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22:1342\u201356.","journal-title":"Eur J Heart Fail"},{"key":"2124_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jech-2015-205738","volume":"70","author":"A Ohlsson","year":"2016","unstructured":"Ohlsson A, Lindahl B, Hanning M, Westerling R. Inequity of access to ACE inhibitors in Swedish heart failure patients: a register-based study. J Epidemiol Community Health. 2016;70:97\u2013103.","journal-title":"J Epidemiol Community Health"},{"key":"2124_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/CIA.S71165","volume":"10","author":"G Damiani","year":"2015","unstructured":"Damiani G, Salvatori E, Silvestrini G, et al. Influence of socioeconomic factors on hospital readmissions for heart failure and acute myocardial infarction in patients 65 years and older: evidence from a systematic review. Clin Interv Aging. 2015;10:237\u201345.","journal-title":"Clin Interv Aging"},{"key":"2124_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2017.09.193","volume":"257","author":"P Par\u00e9n","year":"2018","unstructured":"Par\u00e9n P, Dahlstr\u00f6m U, Edner M, Lappas G, Rosengren A, Schaufelberger M. Association of diuretic treatment at hospital discharge in patients with heart failure with all-cause short- and long-term mortality: a propensity score-matched analysis from SwedeHF. Int J Cardiol. 2018;257:118\u201324.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2124_CR29","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1253\/circj.CJ-11-1196","volume":"76","author":"S Hamaguchi","year":"2012","unstructured":"Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J. 2012;76(8):1920\u20137.","journal-title":"Circ J"},{"issue":"12","key":"2124_CR30","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/eurheartj\/ehi890","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Husain A, Love TE, Gambassi G, Dell\u2019Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27(12):1431\u20139.","journal-title":"Eur Heart J"},{"issue":"1 Pt 1","key":"2124_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0002-8703(99)70251-6","volume":"138","author":"FA McAlister","year":"1999","unstructured":"McAlister FA, Teo KK, Taher M, Montague TJ, Humen D, Cheung L, Kiaii M, Yim R, Armstrong PW. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999;138(1 Pt 1):87\u201394.","journal-title":"Am Heart J"},{"issue":"6","key":"2124_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/euhj.1998.1280","volume":"20","author":"MR Cowie","year":"1999","unstructured":"Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20(6):421\u20138.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02124-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T08:03:25Z","timestamp":1624003405000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02124-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02124-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in accordance with the 1964 Declaration of Helsinki and its later amendments and approved by a Swedish multisite ethics committee and the Central Ethical Review Board in Link\u00f6ping, Sweden, respectively (Approvals Nos. 2012\/285-31 and 2013\/392-32). Individual patient consent was not required for entry into the national SwedeHF registry, but patients were informed of the registry procedure and allowed to opt out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no potential conflicting interests regarding the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}